BSESai Capital LtdMediumNeutral
Announced Thu, 14 Aug · 13:31 IST

Un- Audited Standalone and Consolidated Financial Results for the First Quarter ended on June 30, 2025

Pat NegativeRevenue Growth 20pctPat Growth 25pctResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sai Capital Ltd reported its Q1 FY26 results alongside the 30th AGM notice on September 29, 2025. On a standalone basis, the company continued to generate zero revenue from operations and zero other income, posting a net loss of ₹15.24 lakhs (slightly better than the ₹16.85 lakh loss in Q1 FY25), with negative other equity of ₹696.79 lakhs and a basic EPS of ₹(0.53). On a consolidated basis (which includes subsidiaries Health Care Energy Foods, Unisphere Industries, and Butterfly Ayurveda), revenue from operations jumped about 80% YoY to ₹14.75 lakhs and total income rose to ₹599.58 lakhs, driven mainly by other income. Consolidated profit after tax surged nearly 66% YoY to ₹311.28 lakhs, lifting basic EPS to ₹10.81 from ₹6.39. The board also approved the re-appointment of an independent director and the secretarial auditor for a second term. Statutory auditor Mehrotra & Co. issued an unqualified limited review report.

Likely market impact

For shareholders, the standalone entity remains a shell with no operating income and accumulated losses, but value sits in the subsidiaries which are profitable and growing — this is essentially an investment/holding company structure. The strong consolidated PAT growth may support the stock narrative, though the standalone weakness is a structural concern for long-term holders.